Close Menu

NEW YORK – Agilent Technologies reported after the close of the market on Tuesday that its fiscal first quarter revenues rose 6 percent year over year.

For the three months ended Jan. 31, the firm said revenues rose to $1.36 billion from $1.28 billion a year ago, beating analysts' average estimate of $1.35 billion. The company said core revenues grew 2 percent in Q1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.